Motley Fool Wealth Management, LLC Novo Nordisk A S Transaction History

Motley Fool Wealth Management, LLC

  • $1.87 Billion
  • Q3 2024

A detailed history of Motley Fool Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Motley Fool Wealth Management, LLC holds 112,434 shares of NVO stock, worth $11.6 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
112,434
Previous 123,864 9.23%
Holding current value
$11.6 Million
Previous $17.7 Million 24.28%
% of portfolio
0.71%
Previous 0.96%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $1.36 Million - $1.66 Million
-11,430 Reduced 9.23%
112,434 $13.4 Million
Q2 2024

Aug 08, 2024
SELL
$122.71 - $146.91 $630,729 - $755,117
-5,140 Reduced 3.98%
123,864 $17.7 Million
Q1 2024

May 08, 2024
SELL
$102.11 - $135.92 $6.48 Million - $8.63 Million
-63,464 Reduced 32.97%
129,004 $16.6 Million
Q4 2023

Feb 02, 2024
SELL
$87.78 - $105.45 $208,214 - $250,127
-2,372 Reduced 1.22%
192,468 $19.9 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $8.88 Million - $19.5 Million
97,652 Added 100.48%
194,840 $17.7 Million
Q2 2023

Aug 09, 2023
SELL
$155.98 - $172.65 $143,345 - $158,665
-919 Reduced 0.94%
97,188 $15.7 Million
Q1 2023

May 10, 2023
SELL
$132.34 - $159.14 $222,463 - $267,514
-1,681 Reduced 1.68%
98,107 $15.6 Million
Q4 2022

Feb 09, 2023
SELL
$102.55 - $135.33 $319,956 - $422,229
-3,120 Reduced 3.03%
99,788 $13.5 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $136,345 - $167,326
-1,431 Reduced 1.37%
102,908 $10.3 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $362,991 - $428,283
-3,516 Reduced 3.26%
104,339 $11.6 Million
Q1 2022

May 04, 2022
SELL
$93.1 - $112.54 $5.92 Million - $7.15 Million
-63,535 Reduced 37.07%
107,855 $12 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $136,437 - $166,604
-1,423 Reduced 0.82%
171,390 $19.2 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $103,161 - $130,289
-1,222 Reduced 0.7%
172,813 $16.6 Million
Q2 2021

Aug 13, 2021
BUY
$67.66 - $84.76 $56,022 - $70,181
828 Added 0.48%
174,035 $14.6 Million
Q1 2021

May 11, 2021
BUY
$67.06 - $75.82 $4,828 - $5,459
72 Added 0.04%
173,207 $11.7 Million
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $312,997 - $361,546
4,899 Added 2.91%
173,135 $12.1 Million
Q3 2020

Nov 12, 2020
BUY
$63.69 - $70.22 $434,302 - $478,830
6,819 Added 4.22%
168,236 $11.7 Million
Q2 2020

Aug 12, 2020
SELL
$58.54 - $67.94 $33,894 - $39,337
-579 Reduced 0.36%
161,417 $10.6 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $295,523 - $387,060
-5,975 Reduced 3.56%
161,996 $9.75 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $1,346 - $1,573
-27 Reduced 0.02%
167,971 $9.72 Million
Q3 2019

Nov 12, 2019
SELL
$47.54 - $53.43 $2,804 - $3,152
-59 Reduced 0.04%
167,998 $8.69 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $35,981 - $40,349
769 Added 0.46%
168,057 $8.58 Million
Q1 2019

May 07, 2019
BUY
$46.36 - $52.63 $161,008 - $182,783
3,473 Added 2.12%
167,288 $8.75 Million
Q4 2018

Feb 12, 2019
BUY
$41.54 - $47.25 $208,364 - $237,006
5,016 Added 3.16%
163,815 $7.55 Million
Q3 2018

Nov 06, 2018
BUY
$46.76 - $51.24 $250,773 - $274,800
5,363 Added 3.5%
158,799 $7.49 Million
Q2 2018

Aug 10, 2018
BUY
$44.29 - $50.42 $307,062 - $349,561
6,933 Added 4.73%
153,436 $7.08 Million
Q1 2018

May 04, 2018
BUY
$48.49 - $58.14 $475,202 - $569,772
9,800 Added 7.17%
146,503 $7.22 Million
Q4 2017

Feb 14, 2018
BUY
$47.53 - $53.73 $338,080 - $382,181
7,113 Added 5.49%
136,703 $7.34 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $5.33 Million - $6.38 Million
129,590
129,590 $6.24 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Motley Fool Wealth Management, LLC Portfolio

Follow Motley Fool Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email